Orthofix International N.V. (NASDAQ:OFIX) - Equities research analysts at Jefferies Group issued their Q1 2018 EPS estimates for shares of Orthofix International N.V. in a report released on Monday. Jefferies Group analyst R. Denhoy expects that the medical device company will post earnings per share of $0.45 for the quarter. Jefferies Group also issued estimates for Orthofix International N.V.’s Q2 2018 earnings at $0.43 EPS, Q3 2018 earnings at $0.44 EPS, Q4 2018 earnings at $0.48 EPS and FY2018 earnings at $1.80 EPS.
Other research analysts also recently issued research reports about the company. SunTrust Banks, Inc. began coverage on Orthofix International N.V. in a research note on Tuesday, May 23rd. They set a “buy” rating and a $49.00 target price for the company. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Zacks Investment Research downgraded Orthofix International N.V. from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. BTIG Research began coverage on Orthofix International N.V. in a research note on Wednesday, June 21st. They set a “buy” rating and a $52.00 target price for the company. Finally, Ladenburg Thalmann Financial Services began coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They set a “buy” rating and a $53.25 target price for the company. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $51.88.
TRADEMARK VIOLATION WARNING: This report was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://stocknewstimes.com/2017/08/19/analysts-offer-predictions-for-orthofix-international-n-v-s-q1-2018-earnings-ofix-updated.html.
Shares of Orthofix International N.V. (NASDAQ OFIX) traded down 0.29% during midday trading on Wednesday, hitting $48.19. 48,830 shares of the company were exchanged. The company has a 50-day moving average of $45.44 and a 200 day moving average of $40.49. The company’s market capitalization is $869.54 million. Orthofix International N.V. has a one year low of $32.51 and a one year high of $48.55.
Orthofix International N.V. (NASDAQ:OFIX) last announced its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 10.04%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the company posted $0.41 EPS.
Hedge funds and other institutional investors have recently modified their holdings of the company. Arizona State Retirement System increased its position in shares of Orthofix International N.V. by 1.1% in the second quarter. Arizona State Retirement System now owns 9,400 shares of the medical device company’s stock valued at $437,000 after buying an additional 100 shares during the last quarter. Systematic Financial Management LP boosted its stake in Orthofix International N.V. by 0.6% in the first quarter. Systematic Financial Management LP now owns 44,310 shares of the medical device company’s stock valued at $1,690,000 after buying an additional 260 shares during the period. Victory Capital Management Inc. boosted its stake in Orthofix International N.V. by 1.2% in the second quarter. Victory Capital Management Inc. now owns 32,089 shares of the medical device company’s stock valued at $1,491,000 after buying an additional 365 shares during the period. American International Group Inc. boosted its stake in Orthofix International N.V. by 7.1% in the first quarter. American International Group Inc. now owns 10,783 shares of the medical device company’s stock valued at $411,000 after buying an additional 717 shares during the period. Finally, Gabelli Funds LLC boosted its stake in Orthofix International N.V. by 0.3% in the first quarter. Gabelli Funds LLC now owns 291,450 shares of the medical device company’s stock valued at $11,119,000 after buying an additional 1,000 shares during the period. 99.68% of the stock is owned by hedge funds and other institutional investors.
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.
